Rafferty Asset Management’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Sell |
77,907
-33,193
| -30% | -$212K | ﹤0.01% | 890 |
|
|
2025
Q1 | $540K | Sell |
111,100
-33,620
| -23% | -$163K | ﹤0.01% | 850 |
|
|
2024
Q4 | $1.38M | Buy |
144,720
+699
| +0.5% | +$6.68K | ﹤0.01% | 734 |
|
|
2024
Q3 | $1.2M | Buy |
+144,021
| New | +$1.2M | ﹤0.01% | 761 |
|
|
2023
Q3 | – | Sell |
-581,625
| Closed | -$4.27M | – | 1082 |
|
|
2023
Q2 | $4.27M | Buy |
581,625
+198,538
| +52% | +$1.46M | 0.02% | 452 |
|
|
2023
Q1 | $3.97M | Sell |
383,087
-32,505
| -8% | -$337K | 0.03% | 434 |
|
|
2022
Q4 | $4.91M | Buy |
415,592
+180,609
| +77% | +$2.13M | 0.04% | 377 |
|
|
2022
Q3 | $4.93M | Buy |
234,983
+107,256
| +84% | +$2.25M | 0.05% | 340 |
|
|
2022
Q2 | $3.97M | Sell |
127,727
-18,901
| -13% | -$587K | 0.04% | 330 |
|
|
2022
Q1 | $6.02M | Buy |
146,628
+14,963
| +11% | +$614K | 0.04% | 328 |
|
|
2021
Q4 | $5.72M | Buy |
131,665
+77,075
| +141% | +$3.35M | 0.03% | 328 |
|
|
2021
Q3 | $2.73M | Buy |
54,590
+13,520
| +33% | +$677K | 0.02% | 534 |
|
|
2021
Q2 | $2.59M | Buy |
41,070
+4,124
| +11% | +$260K | 0.02% | 582 |
|
|
2021
Q1 | $3.43M | Buy |
36,946
+25,807
| +232% | +$2.4M | 0.02% | 399 |
|
|
2020
Q4 | $998K | Sell |
11,139
-9,092
| -45% | -$815K | 0.01% | 494 |
|
|
2020
Q3 | $2.09M | Buy |
20,231
+3,754
| +23% | +$388K | 0.03% | 400 |
|
|
2020
Q2 | $1.3M | Buy |
16,477
+11,820
| +254% | +$935K | 0.02% | 472 |
|
|
2020
Q1 | $269K | Sell |
4,657
-34,943
| -88% | -$2.02M | 0.01% | 465 |
|
|
2019
Q4 | $2.14M | Sell |
39,600
-14,963
| -27% | -$807K | 0.03% | 366 |
|
|
2019
Q3 | $2.85M | Sell |
54,563
-51,835
| -49% | -$2.71M | 0.04% | 241 |
|
|
2019
Q2 | $5.14M | Buy |
106,398
+26,947
| +34% | +$1.3M | 0.09% | 159 |
|
|
2019
Q1 | $4.01M | Buy |
+79,451
| New | +$4.01M | 0.06% | 170 |
|